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Abstract: This study was aimed to construct a biodegradable but reliable 3-β-hydroxybutyrate biosensor. In this context a versatile 
paper based biosensor, quickly, easily and cheaply fabricated is reported. The procedure of fabrication is based on the assumption that 
the introduction of the enzyme in the carbon ink will allow enzyme stabilization and facilitate the study of the catalysis of enzymes and 
the detection of substrates. To prove this concept we use the enzyme 3-hydroxybutyrate dehydrogenase, in aqueous solution. This 
enzyme was chosen because it catalyzes the 3-β-hydroxybutyrate, which results from ketoacidosis. The quantification this substance in 
the diabetics’ blood is very important as it can increase the reliability of the diagnosis of glycaemia. To prove the multi-use of this 
biosensor we not only study the redox process in steady state and during the catalytic process, but also detected and quantify the 
3-β-hydroxybutyrate. Our results showed that it was possible to study the redox process that occurred during the catalysis and to 
confirm the amino acid residues that participate in it. It was also observed that glucose and ascorbic acid can interfere in the detection 
and quantification of the 3-β-hydroxybutyrate, what should be in mind when the quantification of the 3-β-hydroxybutyrate is made in 
blood samples. 
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1. Introduction 
The use of glucose sensors coupled POC diagnostic 
devices, also known as glucometers, is one of the most 
used methods nowadays to measure the blood glucose 
concentration. Although it is simple, quick and an easy 
way to measure the glucose concentration, and monitor 
glucose levels, it is expensive since usually diabetics 
should know this information daily, and also is not free 
 
The diabetic population increased and the perception 
of the consequence that it can cause not only to the 
individual (diseases, death, and inability to work) but 
also to the society (health care, economic impact on 
health system) lead to the necessity of its control [1-3]. 
The production of biosensors that can be cheap, easily 
made, reproducible and reliable are a goal that will 
allow the universalization of sensor coupled POC 
(point-of-care) diagnostic devices.  
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of risks [3-10]. In diabetic patients, the ketoacidosis 
analysis is essential to prevent wrong diagnostics in 
diabetics’ type 1. In healthy individuals, normal 
amounts of 3-β-hydroxybutyrate are below 1 mM, in 
individuals with hyperketonaemia this value can range 
from 1 mM to 3 mM [11-12]. 
The rapid determination of 3-β-hydroxybutyrate in 
blood is crucial to a quick and correct diagnosis, but 
only few 3-β-hydroxybutyrate biosensors have been 
reported and some of them are screen-printing 
electrodes [11, 13, 14]. In some of these sensors, lost in 
enzyme activity is reported, and attributed to mediator 
inhibition. They also report interferences with other 
electro active species in solution. 
Some of these amperometric biosensors are based on 
redox mediators’ reactions [15, 16]. The mediators 
used were 1,10-phenanthroline quinine and potassium 
ferricyanide. However, none of these systems detects 
3-β-hydroxybutyrate directly, increasing the system 
complexity and cost.  
D 
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There are many advantages of development 
biosensors that can directly sense the presence of 
3-β-hydroxybutyrate, using a simple enzymatic system 
3-Hydroxybutyrate Dehydrogenase (HBH). In this 
context we developed a simple biosensor that, without 
modification of the surface working electrode, makes 
possible the detection of 3-β-hydroxybutyrate. 
HBH is an oxidoreductase that presents a tetrameric 
structure. In each subunit of the tetrameric enzyme, the 
substrate (D-3-hydroxybutyrate) is trapped on the 
nicotinamide plane of the bound NAD+, and it has 
bounds to the amino acid chain [17] (Fig. 1). 
The methyl group of the NAD+ is accommodated in 
the nearby hydrophobic pocket, which makes possible 
a hydrogen bond from the OH group of the substrate to 
the hydroxyl group of Tyr155 at the active center. A 
comparison of the protein structure with and without 
ligands indicates that the Gln196 residue participates in 
the formation of additional hydrogen bonds. It is likely 
 
 
Fig. 1  PDB crystal structure of a tetramer unit of 
β-3-hydroxybutyrate dehydrogenase from Alcaligenes 
faecalis, complexed with NAD+ (in the middle in yellow) an 
Na atom in the top (purple) near the amino acid chain (light 
blue) and a substrate β-3-hydroxybutyrate (gray and red) 
(PDB code: 5B4T) [16]. Figure prepared with Viewerlite 
program. 
that this situation can facilitate H-atom movements as 
the trigger of the catalytic reaction [17].  
The redox system NADH/NAD+ is very important in 
nature since it is a cofactor of a large number of 
enzymes, but also because it is important in biofuel 
cells and bioreactors [18-20]. However, it is also a 
challenge to develop biosensors, once there is the 
possibility of NAD+ freely lives the enzyme, becoming 
the enzyme in an inactive conformation, but also the 
formation of inactive products (NAD2 dimer). Another 
problem is that the oxidation of NADH is usually 
irreversible, it occurs at high potential, NAD+ act as an 
inhibitor of the direct electrode process or even 
provokes electrode surface poisoning [21-24]. To 
overcome these difficulties, efforts have been made 
using different strategies as surface modification, use 
of mediators [13, 16, 25-27] or use new materials 
(carbon nanofibers, carbon nanotubes, graphene and 
composites) as immobilization matrix for biomolecules 
[18, 19, 22, 28-34]. These paper devices are 
screen-printing electrodes that have an important role 
in the biosensing development, once they have 
numerous applications in biochemical fields [35-38]. 
The versatility of these devices, which can sense 
diverse substances (from metals to enzymes, pesticides, 
antigens, biomolecules) and are easily made, give a 
fundamental place in the electrochemical research 
nowadays.  
We used the system HBH/NAD+ as the key base to 
develop a new biosensor [39, 40]. The electron transfer 
occurs between the redox active enzyme center and the 
electrode surface and allows the use of the redox 
couple NADH/NAD+ as a reliable source of 
information related to the detection of 
3-β-hydroxybutyrate with a β-3-hydroxybutyrate 
dehydrogenase/NAD+ biosensors.  
2. Experimental  
2.1 Materials  
All reagents used were of analytical grade. 
3-hydroxybutyrate dehydrogenase (HBH) from 
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Rhodobacter sphaeroids (aqueous solution (2 mL), 10 
mg), was used with no further purification, 
3-β-hydroxybutyrate, β-nicotinamide adenine 
dinucleotide, reduced disodium salt hydrate (NADH), 
potassium chloride and potassium ferrocyanide were 
acquired from Sigma-Aldrich. All buffers used in this 
work were commercial and purchased from ROTH 
(Germany). The electrolyte was a buffer solution with 
potassium chloride (0.1 M). All solutions were 
prepared with electrolyte. 
2.2 Fabrication of the Biosensor 
The carbon ink and Ag/AgCl ink were purchased 
from Conductive compounds. The ink base of the 
working electrode was the carbon ink in which was 
added enzyme.  
A Xerox Color Qube 8570 printer from Xerox was 
used to print the hydrophobic region of the devices. 
The paper used was Whatman n.01 chromatographic 
paper, and the wax was obtained from Xerox. After the 
wax printing, the wax was heat treated during 10 s in a 
hot plate (150 °C). After that, the paper, cooled at room 
temperature and it was ready to perform the 
screen-printing technique. The configuration system 
designed was a three electrode system with an 
Ag/AgCl reference electrode, a carbon counter 
electrode and a working electrode based in carbon ink. 
The conductive circuit was screen-printed with silver 
ink, which was deposited above the hydrophobic 
matrix (wax). Then the mesh was removed and the 
device was allowed to heat at hot plate (60 °C) during 8 
minutes. Once the construction of the conductive 
circuit was concluded, the counter electrode was 
printed and dried the same way as described before. 
The other two electrodes had the same screen-printing 
treatment. 
2.3 Working Electrode Preparation 
The enzyme, in aqueous solution, and cofactor, in 
the solid state, were mixed with the carbon ink. This 
mixture was used to do the working electrode. 
2.4 Electrochemical Detection 
During the electrochemical measurements, a drop of 
the interest solutions (2 µL) is spotted in the 
hydrophobic channel between the wax-limited zones 
and dispersed through the paper matrix in a few 
seconds, being in contact with the three electrodes. The 
electrochemical behavior of enzyme was experimentally 
characterized through cyclic voltammetry. 
All electrochemical acquisitions and measurements 
were performed in a Gamry ESA419 data acquisition 
system, using PHE 200 physical electrochemical and 
PV 220 physical electrochemical software coupled 
with a Gamry instruments (reference 600) 
potentiostat/galvanostat (ZRA) and the data analysis 
were processed by Gamry software package. All the 
experimental procedure was performed in normal 
atmosphere in the presence of oxygen. 
3. Results and Discussion 
The major goal of this research was to fabricate a 
3-β-hydroxybutyrate biosensor that did not need a 
mediator, as in the previous biosensors reported, which 
not only would decrease the price of the apparatus but 
also nullifies its influence in the biosensor 
detection-mediator inhibition. The simplification and 
the reduction of time-consuming in the biosensor 
manufacture, in comparison to previous ones, were 
another aim of this research (see 2.2 Fabrication of the 
biosensor). To ensure the enzyme activity—one of the 
problems reported in earlier research—the strategy was 
to introduce the enzyme as it was purchased and its 
cofactor NADH, in the working electrode mixture. The 
results obtained are described below. 
3.1 Electrochemistry of HBH Using a Screen-Printing 
Electrode  
With the aim of developing a 3-β-hydroxybutyrate 
(HB) biosensor, a metabolite produced by the human 
body, we developed a screen printing biosensor that 
can sense its presence. To achieve this objective, we 
fabricated a working electrode using a mixture of 
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NADH (35 mg) and HBH (0.25 mg) in carbon ink   
(814 mg). The addition of the cofactor NADH was to 
ensure the enzyme activity.  
The cyclic voltammograms were recorded at room 
temperature (22 °C), at sweep rate between 20-100 
mVs-1. The direct electron transfer between the redox 
active center and the electrode surface occurred at low 
potentials (Fig. 2).  
Two well-defined anodic and cathodic peak currents 
appeared in the voltamogramas. To ensure the 
repeatability of the results, more six experiments were 
conducted in the same conditions using six different 
screen printing electrodes. 
Using the data of the seven experiments, using seven 
different biosensors, it was possible to obtain the 
following results: a well-defined cathodic peak appears 
at Epa = 81 ± 6 mV and anodic peaks, were observed at 
Epc = -134 ± 27 mV. A peak-to-peak separation, ∆Ep, 
with a value of (232 ± 14) mV vs Ag/AgCl (n = 7) was 
obtained and a formal potential of E0’ = (-26.5 ± 10) 
mV vs. Ag/AgCl (n = 7) was calculated. A ratio of 
anodic to cathodic peaks current, |ipa/ipc| was also 
estimated near the unit. Although Ep and ip/v1/2 are 
independent of the scan rate, |ipa/ipc| is near the unit, 
peak-to-peak variation, ∆Ep, is far from the theoretical 
value (59/n (mV), n = electron number). The 
parameters obtained in these experiences reflect a 
quasi-reversible redox process, controlled by diffusion 
[40-42].  
3.2 Catalysis of 3-β-Hydroxybutyrate by HBH Using a 
Screen-Printing Electrode  
Cyclic voltammetry was used to analyze the 
behavior of HBH in the presence of increasing 
concentrations of HB. The direct catalysis of 
3-hydroxybutyrate dehydrogenase (HBH) activated 
(HBH with cofactor—NADH) in pH 7 was observed. 
The voltammetric data obtained in these conditions at 
the screen printing electrodes were assigned to the 
redox process involving the NADH and the HBH 
catalytic center. An increase in the cathodic peak 
current was observed during 3-β-hydroxybutyrate 
additions. The calibration curve in the presence of 
different concentrations of HB is shown in Fig. 3. 
 
 
Fig. 2  Cyclic voltammograms at a screen at a screen printing electrode with a three electrode system configuration with an 
Ag/AgCl reference electrode, a carbon counter electrode and a working electrode with NADH (35 mg) and HBH (0.25 mg) in 
carbon ink (814 mg) in 2 µL of PBS (7.0) with KCl (0.1M). Insertion: Variation of the anodic and cathodic peak current with 
the square root of the sweep rate. (◌) ipa = 2.627v1/2 + 0.118 µA, R = 0.99, n = 7; (△)ipc = -2.592 v1/2 + 0.076 µA, R = 0.99, n = 7).  
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Fig. 3  Variation in the anodic catalytic current of HBH with 3-β-hydroxybutyrate concentration detected at screen printing 
electrode with a three electrode system configuration with an Ag/AgCl reference electrode, a carbon counter electrode and a 
working electrode with NADH and HBH in carbon ink. The voltammograms were recorded in 2 µL of PBS (7.0) with KCl (0.1 
M) with different 3-β-hydroxybutyrate concentration. Insertion: Michaelis-Menten Lineweaver-Burk linearization: 1/ipa = 
0.6561/[3-β-hydroxybutyrate] + 0.4332, R² = 0.9965, Km = 1.54 mM, Icat max = 2.3 mM. The best curve fit to Michaelis-Menten 
kinetics (__); Linear variation of anodic catalytic current between 1 and 3 mM of 3-β-hydroxybutyrate was ipa = 0.330 
[3-β-hydroxybutyrate] + 0.603, R² = 0.9936, n = 3 (three measurements) for each point (__). 
 
The addition of 3-β-hydroxybutyrate produced a 
slight change in the electrochemistry parameters to: 
∆Ep = (239 ± 15) mV vs. Ag/AgCl (n = 13), and the 
estimated E0’ = (-22.0 ± 9) mV vs. Ag/AgCl (n = 13). 
The formal potential, E0’, is near the value obtained in 
buffer solution signifying that the redox groups 
responsible for the catalytic process and for oxidation 
and reduction in non-turnover conditions are the same.  
The reaction that occurs in the catalytic center is the 
following one: 
     (1) 
The curve was adjusted to Michaelis-Menten 
enzyme kinetics description and constant values were 
estimated from cyclic voltammetric experiments   
(Fig. 3). The Km values were found to be (1.52 ± 0.03) 
mM. The values reported in the literature for a 
screen-printed iridium—modified working electrode 
was (2.26 ± 0.238 mM, at 25.8 °C) [13] and with 
Single-walled carbon nanotubes—modified screen 
printing electrode (SWCNT-modified SPCE) were 
4.61 mM (pH 7.5) [14] and 0.41 mM at pH 8.5    
(0-33 mMNAD) [42]. These data are near and in the 
same order of magnitude of the present. Although the 
Km parameters can be used to evaluate the enzyme 
activity, it is possible to see that the Km values diminish 
with the temperature and that at 37.5 °C its value is       
(1.83 ± 0.302) mM [13].  
It is possible to use the linear fit between 1 mM and 
3 mM of β-hydroxybutyrate to identify the ketone 
quantity present in blood samples, Fig. 3. This 
detection range is useful to perceive the ketonaemia 
and can be used for clinical measurements. 
These electrodes were also used to examine the 
formal potential variation with the pH in the presence 
of 3-β-hydroxybutyrate (10 mM) (Fig. 4). 
The formal potential in electrolytes is almost 
constant in all the pH range (Insertion), but after the 
addition of 3-β-hydroxybutyrate it varies (Fig. 4). From 
the experimental data it was possible to estimate   
pKa1 = 4.0, pKa2 = 10.2. These constants can be attributed 
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Fig. 4  Variation the formal potential with the pH. The best 
curve fit allowed the estimation of pKa1 = 4.0, pKa2 = 10.2. 
Measurements with different electrodes each point is the 
media of two measurements with different electrodes. 
Insertion: formal potential variation with the pH.  
 
to the aspartic acid (pKa 3.9) or glutamic acid (pKa 4.0) 
and Tyrosine (10.46) respectively [43]. In fact, near the 
catalytic center there is one residue that has an 
important paper in the catalysis, Trp155. It is 
worthwhile to mention that in crystal structure the HB 
is the molecule that binds to the catalytic center (not 
acetoacetate), as well as NAD+ (not NADH). 
Hydrophilic interactions are established in the complex 
HBH-NAD+-HB thought the bounded of HBH by the 
two carboxylate oxygen’s through four hydrogen 
bonds. But HB is also accommodated in a hydrophobic 
pocket surrounded by Ala143, His144 and Trp187 e 
Trp257 [17]. So these experimental results are in 
agreement with the crystal data. 
3.3 Influence of Interferentes Species in the Catalysis of 
HBH 
The main goal of this project was to construct an 
electrode that could be used to analyze diabetic’s blood. 
So it was necessary to examine the interference of 
glucose and ascorbic acid usually present in blood. The 
rapid detection of these three compounds (glucose, 
ascorbic acid and 3-β-hydroxybutyrate) in serum and 
blood may permit a reliable diagnose not only of 
glycaemia but also of ketonaemia. In order to analyze 
the specificity of this sensor, the formal potential signal 
variation with glucose was studied. In amounts 
between 5-150 mM the glucose presence did not 
implicate a change in formal potential, E0’ = (-32 ± 5) 
mV vs. Ag/AgCl. These findings indicate that the 
redox center where glucose is being detected is also the 
catalytic center. The catalytic currents ipcat, calculated 
as the rate ipa after/ipa before glucose addition, had an 
increase in low concentration, but to values higher than 
25 mM there was a decrease, and after 50 mM the ipcat 
values do not change with glucose addition (Fig. 5).  
Nevertheless, in healthy people the glucose range is 
from 4.4 mM to 6.6 mM [3]. So, to use this electrode in 
real samples we must do careful analysis of the results 
because glucose may compete with HB, increasing 
artificially the electrochemical signal which may be 
read as an increase in HB amounts. 
The presence of ascorbic acid was also studied. The 
electrochemical signal variation, before and after the 
addition of ascorbic acid was analyzed. In quantities in 
the range of 28 µM to 2.8 mM the catalytic current (rate 
ipa after/ipa before the addition) was 1.36 ± 0.09. 
However, for  concentrations  higher  than  2.8 mM a 
 
 
Fig. 5  Variation of ipcat (ipa after/ipa before glucose addition) 
with glucose concentration. The cyclic voltammograms were 
recorded with a scan rate 100 mVs-1 in the electrolyte (PBS 
Buffer (pH 7) with KCl (0.1 M)), in the presence of HB   
(10 mM). 
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greater increase in catalytic current peaks is observed. 
It is interesting to highlight that the maximum quantity 
of ascorbic acid in plasma in a recent study was 
reported to be 100 µmol/L [44], and the reference range 
in the blood is between 34 µmol/L and 113 µmol/L. So 
with this in mind, and the slight increase observed in 
the catalytic current for concentrations below 2.8 mM, 
it’s necessary to look at the results carefully when a 
clinical diagnosis is done. It is clear from our data that 
not only the presence glucose can induce in mistaken 
diagnoses of hyperketonaemia but also the ascorbic 
acid.  
4. Conclusions 
In this work we used a simple but efficient procedure 
to immobilize the enzyme (3-hydroxybutyrate 
dehydrogenase) and the cofactor (NADH) in the matrix 
of the working electrode. We use the cofactor NADH 
to ensure the enzyme activity. This method does not 
need any drastic treatment, so the enzyme maintains 
the native conformation without denaturation. This 
fabrication proceeding also allowed not only the 
detection and quantifications of the 
3-β-hydroxybutyrate in the range of interest 1-3 mM, 
but also the catalysis study. 
It was possible to verify that the catalytic center was 
also the redox center in non-turnover conditions, and 
we also could identify the amino acid responsible for 
that (Trp). This attribution was based on experimental 
data that corroborate the crystallographic data’s 
publish recently. 
It’s important to highlight that this research is driven 
by the need of a more reliable diagnosis of diabetes, 
and the development of biodegradable, cheap but 
reliable 3-β-hydroxybutyrate biosensors. In future 
research, this biosensor should be tested with human 
blood, to evaluate its efficacy, reliability and 
usefulness in in vivo situations.  
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